Key result
PAI-1 4G/5G polymorphism is linked to plasma PAI-1 activity, modifying lipid correlations by dyslipidemia status.
Observational
Answers are grounded in this paper and cite their sources.
The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene-environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur.
No takes yet. Share an insight, caveat, or question.
Burzotta et al. (1998) conducted an observational in Dyslipidemia. 4G/5G PAI-1 gene promoter polymorphism vs. Different 4G/5G genotype classes was evaluated on Plasma PAI-1 activity and its correlation with cholesterol and triglycerides. The 4G/5G PAI-1 gene promoter polymorphism was associated with plasma PAI-1 activity in Italians, modifying correlations with cholesterol and triglycerides by dyslipidemia status.
Synapse has enriched 10 related papers. Consider them for comparative context: